HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji-Eun Kim Selected Research

Status Epilepticus (Complex Partial Status Epilepticus)

5/2022CDDO-Me Attenuates CA1 Neuronal Death by Facilitating RalBP1-Mediated Mitochondrial Fission and 4-HNE Efflux in the Rat Hippocampus Following Status Epilepticus.
4/2022Glutathione Regulates GPx1 Expression during CA1 Neuronal Death and Clasmatodendrosis in the Rat Hippocampus following Status Epilepticus.
2/2021LONP1 Regulates Mitochondrial Accumulations of HMGB1 and Caspase-3 in CA1 and PV Neurons Following Status Epilepticus.
1/2021Protein disulfide isomerase-mediated S-nitrosylation facilitates surface expression of P2X7 receptor following status epilepticus.
1/2021Regional specific activations of ERK1/2 and CDK5 differently regulate astroglial responses to ER stress in the rat hippocampus following status epilepticus.
11/2020Blockade of 67-kDa Laminin Receptor Facilitates AQP4 Down-Regulation and BBB Disruption via ERK1/2-and p38 MAPK-Mediated PI3K/AKT Activations.
10/2020CDDO-Me Distinctly Regulates Regional Specific Astroglial Responses to Status Epilepticus via ERK1/2-Nrf2, PTEN-PI3K-AKT and NFκB Signaling Pathways.
9/2020Epigallocatechin-3-Gallate and PEDF 335 Peptide, 67LR Activators, Attenuate Vasogenic Edema, and Astroglial Degeneration Following Status Epilepticus.
1/2020CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NFκB- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus.
11/2019TRPC6-Mediated ERK1/2 Activation Increases Dentate Granule Cell Resistance to Status Epilepticus Via Regulating Lon Protease-1 Expression and Mitochondrial Dynamics.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji-Eun Kim Research Topics

Disease

46Status Epilepticus (Complex Partial Status Epilepticus)
05/2022 - 03/2007
34Neoplasms (Cancer)
01/2021 - 07/2008
27Epilepsy (Aura)
04/2022 - 09/2005
20Disseminated Intravascular Coagulation
02/2016 - 01/2007
17Inflammation (Inflammations)
04/2022 - 01/2011
16Edema (Dropsy)
11/2020 - 11/2010
13Lung Neoplasms (Lung Cancer)
01/2019 - 07/2008
11Seizures (Absence Seizure)
04/2021 - 05/2008
8Fibrosis (Cirrhosis)
04/2022 - 01/2013
8Carcinogenesis
01/2021 - 07/2008
8Obesity
01/2021 - 11/2006
8Breast Neoplasms (Breast Cancer)
01/2020 - 12/2010
7Gliosis
01/2021 - 03/2010
7Alzheimer Disease (Alzheimer's Disease)
01/2018 - 02/2006
7Body Weight (Weight, Body)
05/2016 - 11/2006
6Neuroinflammatory Diseases
04/2022 - 06/2012
6Thrombophilia
01/2019 - 02/2009
5Temporal Lobe Epilepsy
03/2022 - 10/2008
5Necrosis
02/2021 - 06/2009
5Neoplasm Metastasis (Metastasis)
01/2020 - 03/2009
5Thrombosis (Thrombus)
05/2014 - 09/2008
4Brain Diseases (Brain Disorder)
01/2022 - 03/2016
4Chronic Renal Insufficiency
05/2019 - 08/2012
4Sepsis (Septicemia)
02/2019 - 03/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
04/2022 - 09/2012
3Stroke (Strokes)
04/2022 - 07/2004
3Infections
02/2022 - 03/2014
3Atherosclerosis
01/2022 - 01/2015
3Constipation
11/2021 - 03/2014
3Osteoporosis
05/2021 - 07/2015
3Pain (Aches)
04/2021 - 01/2018
3Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 12/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2019 - 02/2013
3Asthma (Bronchial Asthma)
11/2017 - 11/2013
3Hyperglycemia
01/2017 - 01/2010

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
04/2022 - 05/2005
20Dacarbazine (DIC)FDA LinkGeneric
02/2016 - 01/2007
19Pilocarpine (Ocusert)FDA LinkGeneric
04/2021 - 10/2006
10AcidsIBA
05/2022 - 12/2007
10Biomarkers (Surrogate Marker)IBA
04/2022 - 10/2009
9Small Interfering RNA (siRNA)IBA
01/2022 - 07/2008
9ThrombinFDA Link
01/2019 - 02/2009
8Purinergic P2X7 ReceptorsIBA
01/2021 - 10/2010
8CytokinesIBA
01/2021 - 03/2004
7bardoxolone methylIBA
05/2022 - 01/2019
7AntioxidantsIBA
01/2022 - 01/2010
7Pharmaceutical PreparationsIBA
01/2020 - 03/2010
7LipidsIBA
01/2018 - 09/2012
6Messenger RNA (mRNA)IBA
01/2022 - 01/2007
6Phosphotransferases (Kinase)IBA
04/2021 - 01/2010
6CholesterolIBA
01/2021 - 09/2011
6AnticoagulantsIBA
01/2016 - 12/2009
6AerosolsIBA
11/2013 - 07/2008
5Glutamic Acid (Glutamate)FDA Link
04/2022 - 05/2011
5LipopolysaccharidesIBA
04/2022 - 09/2013
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2012
5HMGB1 Protein (HMG1)IBA
02/2021 - 03/2017
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 06/2011
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 03/2010
5Therapeutic UsesIBA
11/2017 - 09/2012
5FibrinIBA
12/2016 - 02/2009
5OsteopontinIBA
08/2015 - 12/2010
4Dynamins (Dynamin)IBA
04/2022 - 10/2015
4Hormones (Hormone)IBA
11/2021 - 03/2019
4Histones (Histone)IBA
01/2021 - 06/2015
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2020 - 05/2008
4p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 05/2015
4AntibodiesIBA
05/2019 - 01/2014
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2019 - 06/2011
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 06/2009
4DNA (Deoxyribonucleic Acid)IBA
01/2019 - 12/2008
4Glial Fibrillary Acidic ProteinIBA
01/2018 - 04/2009
4Nogo Receptor 1IBA
12/2008 - 10/2004
3EstersIBA
05/2022 - 07/2012
3Triglycerides (Triacylglycerol)IBA
03/2022 - 11/2006
3LeptinIBA
01/2022 - 11/2006
3LigandsIBA
01/2022 - 11/2014
3Aquaporins (Water Channels)IBA
11/2021 - 03/2011
3Loperamide (Imodium)FDA LinkGeneric
11/2021 - 03/2014
3GYKI 52466IBA
08/2021 - 12/2020
3AMPA Receptors (AMPA Receptor)IBA
08/2021 - 12/2020
3perampanelIBA
08/2021 - 12/2020
3CalciumIBA
05/2021 - 06/2013
3ParvalbuminsIBA
02/2021 - 03/2007
3Adenosine Triphosphate (ATP)IBA
01/2021 - 01/2018
3GinsenosidesIBA
01/2021 - 01/2019
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2020 - 05/2017
3Peptides (Polypeptides)IBA
09/2020 - 02/2006
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2020 - 08/2011
3CreatinineIBA
05/2019 - 08/2014
3Estrogens (Estrogen)FDA Link
03/2019 - 08/2014
3Biological ProductsIBA
01/2019 - 03/2015
3EnzymesIBA
01/2019 - 01/2010
3Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019 - 11/2014

Therapy/Procedure

22Therapeutics
04/2022 - 07/2004
5Drug Therapy (Chemotherapy)
01/2021 - 12/2010
4Oral Administration
09/2015 - 09/2012
3Ligation
02/2019 - 01/2019
3Punctures
02/2019 - 01/2019
3Electrodes (Electrode)
01/2018 - 11/2010